Challenges in the anticipation of biosimilars: how must a P&T committee gear up?
Tadlock
Celynda
C
The Pharmacy & Therapeutics Society, Glastonbury, CT, USA.
D017277:Drug Approval; D016568:Drugs, Generic / Q000592:standards*; D005569:Formularies as Topic; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic